Jan 15, 2025
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo(TM) (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
Mar 18, 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Dec 09, 2019
Syndax Announces Preclinical Results Supporting Development of its Portfolio of Menin Inhibitors In Mixed Lineage Leukemias
Oct 31, 2019
Syndax to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 7, 2019
Jul 31, 2019
Syndax to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 7, 2019
Mar 27, 2019
Syndax Announces $26.2 Million Offering of Common Stock and Warrants
Dec 03, 2018
Syndax Pharmaceuticals Announces Presentation of Preclinical Data from Menin-MLL Program at the 60th American Society of Hematology Annual Meeting
Nov 05, 2018
Syndax Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Clinical and Business Update
Oct 29, 2018
Syndax to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 5, 2018
Sep 25, 2018
Syndax Announces Changes to its Board of Directors
Aug 07, 2018
Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update
May 30, 2018
Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
May 30, 2018
Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
May 08, 2018
Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
Apr 25, 2018
Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
Apr 13, 2018
Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting
Feb 01, 2018
Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
Jan 10, 2018
Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
Sep 20, 2017
Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference